Yubo International Biotech Limited Quick Ratio (MAGAA) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Yubo International Biotech Limited  (MAGAA)

Yubo International Biotech Limited's Quick Ratio

MAGAA's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 0.01 below Yubo International Biotech Limited average.

Within Medical Equipment & Supplies industry 203 other companies have achieved higher Quick Ratio than Yubo International Biotech Limited in second quarter 2026. While Quick Ratio total ranking has improved so far during the Q2 2026 to 4529, from total ranking in the first quarter 2026 at 5431.

Explain Quick Ratio?
How much Cash & cash equivalents MAGAA´s has?
What are MAGAA´s Current Liabilities?




MAGAA Quick Ratio (Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
Y / Y Current Liabilities Change -33.79 % -36.85 % -40.88 % -43.08 % 27.15 %
Y / Y Cash & cash equivalent Change -23.55 % -56.36 % -86.58 % -1.33 % -68.61 %
Quick Ratio MRQ 0.01 0.01 0.01 0.01 0.01
MAGAA's Total Ranking # 4529 # 5431 # 5178 # 5370 # 5422
Seq. Current Liabilities Change 10.2 % 8.18 % 9.24 % -49.15 % 5.1 %
Seq. Cash & cash equivalent Change 77.26 % 1.33 % -57.78 % 0.8 % 1.18 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 204
Healthcare Sector # 913
Overall Market # 4401


Quick Ratio Statistics
High Average Low
1.25 0.05 0
(Mar 31 2021)   (Feb 29 2020)




Financial Statements
Yubo International Biotech Limited's Current Liabilities $ 3 Millions Visit MAGAA's Balance sheet
Yubo International Biotech Limited's Cash & cash equivalent $ 0 Millions Visit MAGAA's Balance sheet
Source of MAGAA's Sales Visit MAGAA's Sales by Geography


Cumulative Yubo International Biotech Limited's Quick Ratio

MAGAA's Quick Ratio for the trailling 12 Months

MAGAA Quick Ratio

(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
(Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth -38.51 % -25.38 % -9.16 % 11.25 % 38.5 %
Y / Y Cash & cash equivalent TTM Growth -57.46 % -65.76 % -67.67 % -42.27 % -51.83 %
Quick Ratio TTM 0.01 0.01 0.01 0.01 0.01
Total Ranking TTM # 4035 # 4663 # 3515 # 3580 # 3568
Seq. Current Liabilities TTM Growth -12.68 % -11.63 % -11.3 % -10.17 % 5.98 %
Seq. Cash & cash equivalent TTM Growth -8.22 % -16.28 % -44.51 % -0.22 % -26.12 %


On the trailing twelve months basis In spite of the year on year decrease in MAGAA's Current Liabilities to $3.33 millions, cumulative Quick Ratio to 0.01 below the MAGAA average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 207 other companies have achieved higher Quick Ratio than Yubo International Biotech Limited. While Quick Ratio overall ranking has improved so far to 0, from total ranking during the twelve months ending first quarter 2026 at 4006.

Explain Quick Ratio?
How much Cash & cash equivalents MAGAA´s has?
What are MAGAA´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 208
Healthcare Sector # 914
Within the Market # 4529


trailing twelve months Quick Ratio Statistics
High Average Low
0.31 0.03 0
(Jun 30 2021)   (Nov 30 2017)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Dror Ortho-Design, Inc.  0.02 $ 0.085  Millions$ 4.100  Millions
Nu med Plus Inc   0.02 $ 0.005  Millions$ 0.280  Millions
Enovis Corp  0.02 $ 12.563  Millions$ 735.625  Millions
Agape Atp Corporation  0.02 $ 0.045  Millions$ 2.939  Millions
Mountain Crest Acquisition Corp V  0.01 $ 0.018  Millions$ 1.778  Millions
Yubo International Biotech Limited  0.01 $ 0.028  Millions$ 3.328  Millions
Stimcell Energetics Inc   0.01 $ 0.003  Millions$ 0.394  Millions
Picard Medical Inc   0.01 $ 0.038  Millions$ 7.451  Millions

Date modified: 2026-08-15T07:30:26+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.